Compound 44
Identifiers
- Canonical SMILES:
CCOC(=O)c1nc(-c2cccc(C)c2)n(c1-c1cccc(Cl)c1)-c1cc(Cl)ccc1C
- InChi:
InChI=1S/C26H22Cl2N2O2/c1-4-32-26(31)23-24(18-8-6-10-20(27)14-18)30(22-15-21(28)12-11-17(22)3)25(29-23)19-9-5-7-16(2)13-19/h5-15H,4H2,1-3H3
- InChiKey:
XHFIHYLBYMLITD-UHFFFAOYSA-N
External links
67954257 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 5.45 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 464.11 g/mol | |||
HBA | 4 | |||
HBD | 0 | |||
HBA + HBD | 4 | |||
AlogP | 7.16 | |||
TPSA | 44.12 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011023677 | 47 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 5.45 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4821 | Flumazenil | DB01205 | |
0.4756 | Iomazenil | DB14971 | |
0.4556 | Etomidate | DB00292 | |
0.4491 | Azeliragon | DB12689 | |
0.4315 | ABP-700 | DB15411 | |
0.4254 | Conivaptan | DB00872 | |
0.4225 | 123I-iodometomidate | DB13021 | |
0.4194 | 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide | DB03509 | |
0.4170 | Olmesartan | DB00275 | |
0.4128 | Cimicoxib | DB05095 | |
0.4118 | 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE | DB06953 | |
0.4084 | N-6022 | DB12206 | |
0.4083 | 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium | DB04055 | |
0.4071 | Miransertib | DB14982 | |
0.4061 | 2-phenyl-1H-imidazole-4-carboxylic acid | DB07803 |